Name
DeepQure Inc.
Company Description
DeepQure is a clinical-stage medical device company redefining cardiovascular intervention with its extravascular renal denervation (RDN) platform, HyperQure™.
HyperQure™ is the world’s first laparoscopic RDN system designed for precise, 360° circumferential ablation of renal nerves from outside the vessel.
HyperQure™ ensures comprehensive nerve ablation regardless of anatomical complexity while eliminating the risk of vascular endothelial damage.
Global trials are underway, including FIH study in Korea and an FDA approved EFS at six prominent US institutions. Interim results look promising, with average SBP drop of >50mmHg, addressing the efficacy shortfall of current devices and potentially offering a “cure” for hypertension.
DeepQure is also expanding its platform to treat Afib and other autonomic cardiovascular conditions.
Visit our booth at ACC.26 to see how we are shaping the future of interventional therapy and unlocking new pathways in cardiovascular care
HyperQure™ is the world’s first laparoscopic RDN system designed for precise, 360° circumferential ablation of renal nerves from outside the vessel.
HyperQure™ ensures comprehensive nerve ablation regardless of anatomical complexity while eliminating the risk of vascular endothelial damage.
Global trials are underway, including FIH study in Korea and an FDA approved EFS at six prominent US institutions. Interim results look promising, with average SBP drop of >50mmHg, addressing the efficacy shortfall of current devices and potentially offering a “cure” for hypertension.
DeepQure is also expanding its platform to treat Afib and other autonomic cardiovascular conditions.
Visit our booth at ACC.26 to see how we are shaping the future of interventional therapy and unlocking new pathways in cardiovascular care
Website
Product Categories (20)
Interventional - Peripheral
Featured Exhibitor
Yes
Address
5F 9, Yeoksam-ro 7-gil Gangnam-gu
Seoul, 06243
Seoul, 06243
Badges
Listings
Relevance